Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024

BUY
$114.26 - $136.0 $617,004 - $734,400
5,400 Added 227.46%
7,774 $956,000
Q3 2023

Nov 14, 2023

BUY
$122.0 - $145.31 $60,390 - $71,928
495 Added 26.34%
2,374 $307,000
Q2 2023

Aug 09, 2023

BUY
$122.5 - $147.16 $2,572 - $3,090
21 Added 1.13%
1,879 $232,000
Q1 2023

May 15, 2023

BUY
$133.98 - $160.47 $8,574 - $10,270
64 Added 3.57%
1,858 $271,000
Q4 2022

Feb 14, 2023

BUY
$129.72 - $159.85 $232,717 - $286,770
1,794 New
1,794 $285,000
Q3 2020

Nov 13, 2020

SELL
$105.46 - $144.13 $5,273 - $7,206
-50 Closed
0 $0
Q2 2020

Aug 13, 2020

BUY
$95.68 - $121.88 $4,784 - $6,094
50 New
50 $6,000

Others Institutions Holding JAZZ

About Jazz Pharmaceuticals plc


  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $7.71B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track This Portfolio

Track Cetera Advisor Networks LLC Portfolio

Follow Cetera Advisor Networks LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cetera Advisor Networks LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cetera Advisor Networks LLC with notifications on news.